Increased Delay in Diagnosis, but Not Treatment, Among Patients With Oral Cancer During the COVID-19 Pandemic

Giudice, Giovanni; Colella, Giuseppe; Boschetti, Ciro Emiliano; Colella, Chiara; Tartaro, Gianpaolo; Cirillo, Nicola

doi:10.1001/jamaoto.2022.3652

Cited by 8 publications

(5 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This kind of evidence should be considered with the scarcity of papers that evaluate this kind of multidisciplinary approach and the possible collaboration between these two specialists [29][30][31]. The lack of scientific papers evaluating the important relationship between therapies and outcomes with such multidisciplinary approach should be further analyzed and studied including besides this epidemiological evaluation of clinical studies with long-term follow-up [32,33].…”

Section: Collaboration Landscape: Speech Language Therapistsmentioning

confidence: 99%

The professional interactions between speech language therapist and dentist

Costanzo,

Puleio,

Lo Giudice

et al. 2024

Exploration of Medicine

View full text Add to dashboard Cite

Aim: This study investigates the collaborative efforts between speech language therapists and dentists to address the challenges faced by patients with concurrent dental and speech issues. It underscores the importance of understanding the complex interactions within the craniofacial system and its implications for both oral health and communication abilities. Methods: A questionnaire-based research was conducted involving speech language therapists and dentists, using Google Forms as the medium of data collection. This study was disseminated through professional networks, where practitioners provided information on their demographics, practices of collaboration, and the perceived advantages of such interdisciplinary work. All ethical standards were adhered to, ensuring the confidentiality and informed consent of the participants. Results: The findings indicate that dentists, often see first patient visits beyond recommended ages primarily for existing conditions, deviating from preventive norms. About half communicate monthly with speech language therapists, revealing gaps in early care and collaboration. Speech language therapists focus on language disorders and orofacial myofunctional disorders (SMOF), with 37% collaborating frequently with dentists. This interaction highlights the potential for enhanced patient outcomes through interdisciplinary cooperation. Despite these challenges, both groups acknowledged the benefits of their collaborative efforts. Conclusions: The partnership between speech language therapists and dentists represents a vital area of healthcare, aimed at tackling the complex issues of oral health and communication through a multidisciplinary approach. Although obstacles in collaboration were identified, the positive outcomes observed from such partnerships emphasize the importance of developing a unified framework to improve integrated healthcare delivery in the future.

show abstract

Section: Collaboration Landscape: Speech Language Therapistsmentioning

confidence: 99%

The professional interactions between speech language therapist and dentist

Costanzo,

Puleio,

Lo Giudice

et al. 2024

Exploration of Medicine

View full text Add to dashboard Cite

show abstract

“…Several studies have reported disparities associated with access to care during the COVID-19 pandemic, which may have affected stage at presentation and survival outcomes of patients with cancer, especially among individuals with limited access to care . However, although studies have described the epidemiology and outcomes of HNC associated with the COVID-19 pandemic, the generalizability of these studies to the HNC population in the US has been limited, as most have been either from a single institution, aggregated data from multiple institutions, or studies with data outside of the US . Thus, because of the lack of population-based data, whether or to what extent the COVID-19 pandemic affected diagnoses of HNC in the US is unclear.…”

Section: Introductionmentioning

confidence: 99%

“…[10][11][12] However, although studies have described the epidemiology and outcomes of HNC associated with the COVID-19 pandemic, the generalizability of these studies to the HNC population in the US has been limited, as most have been either from a single institution, aggregated data from multiple institutions, or studies with data outside of the US. 7,9,[13][14][15][16][17][18][19] Thus, because of the lack of population-based data, whether or to what extent the COVID-19 pandemic affected diagnoses of HNC in the US is unclear. Also, the understanding of population-based changes in the stage of presentation of HNC during the COVID-19 pandemic is limited.…”

mentioning

confidence: 99%

Head and Neck Cancer Incidence in the United States Before and During the COVID-19 Pandemic

Semprini,

Pagedar,

Boakye

et al. 2024

JAMA Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

ImportanceResearch about population-level changes in the incidence and stage of head and neck cancer (HNC) associated with the COVID-19 pandemic is sparse.ObjectiveTo examine the change in localized vs advanced HNC incidence rates before and during the first year of the pandemic.Design, Setting, and ParticipantsIn this cross-sectional study of patients in the US diagnosed with HNC from 2017 to 2020, the estimated number with cancer of the oral cavity and pharynx (floor of mouth; gum and other mouth; lip; oropharynx and tonsil; and tongue) and larynx were identified from the SEER cancer registry. Subgroup analyses were stratified by race and ethnicity, age, and sex. Data were analyzed after the latest update in April 2023.ExposureThe COVID-19 pandemic in 2020.Main Outcomes and MeasuresThe primary outcomes were the annual incidence rates per 100 000 people for localized HNC (includes both localized and regional stages) and advanced HNC (distant stage) and weighted average annual percentage change from 2019 to 2020. Secondary outcomes included annual percentage change for 2017 to 2018 and 2018 to 2019, which provided context for comparison.ResultsAn estimated 21 664 patients (15 341 [71%] male; 10 726 [50%] ≥65 years) were diagnosed with oral cavity and pharynx cancer in 2019 in the US, compared with 20 390 (4355 [70%] male; 10 393 [51%] ≥65 years) in 2020. Overall, the HNC incidence rate per 100 000 people declined from 11.6 cases in 2019 to 10.8 in 2020. The incidence rate of localized cancer declined to 8.8 cases (−7.9% [95% CI, −7.5 to −8.2]) from 2019 to 2020. The localized cancer incidence during the first year of the pandemic decreased the most among male patients (−9.3% [95% CI, −9.2 to −9.5]), Hispanic patients (−12.9% [95% CI, −12.9 to −13.0]), and individuals with larynx cancer (−14.3% [95% CI, −13.6 to −15.0]). No change in the overall incidence rate was found for advanced HNC.Conclusions and RelevanceIn this cross-sectional study, the incidence of localized HNC declined during the first year of the pandemic. A subsequent increase in advanced-stage diagnoses may be observed in later years.

show abstract

“…However, relatively few studies have attempted to estimate the actual delay experienced by individual patients. The compensation effects of system adaptation on resource capacity (e.g., adjustment of treatment regimen/protocols) by oncologists might have resulted in more personalized treatments without lengthening their delays during the COVID-19 pandemic, as shown in several cancer types [19,20]. To date, real-time data on this aspect is still scarce.…”

Section: Introductionmentioning

confidence: 99%

Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study

Zhou,

Robert,

Seegers

et al. 2024

PLoS ONE

View full text Add to dashboard Cite

Background Longer times between diagnosis and treatments of cancer patients have been estimated as effects of the COVID-19 pandemic. However, relatively few studies attempted to estimate actual delay to treatment at the patient level. Objective To assess changes in delays to first treatment and surgery among newly diagnosed patients with localized breast cancer (BC) during the COVID-19 pandemic. Methods We used data from the PAPESCO-19 multicenter cohort study, which included patients from 4 French comprehensive cancer centers. We measured the delay to first treatment as the number of days between diagnosis and the first treatment regardless of whether this was neoadjuvant chemotherapy or surgery. COVID-19 pandemic exposure was estimated with a composite index that considered both the severity of the pandemic and the level of lockdown restrictions. We ran generalized linear models with a log link function and a gamma distribution to model the association between delay and the pandemic. Results Of the 187 patients included in the analysis, the median delay to first treatment was 42 (IQR:32–54) days for patients diagnosed before and after the start of the 1st lockdown (N = 99 and 88, respectively). After adjusting for age and centers of inclusion, a higher composite pandemic index (> = 50 V.S. <50) had only a small, non-significant effect on times to treatment. Longer delays were associated with factors other than the COVID-19 pandemic. Conclusion We found evidence of no direct impact of the pandemic on the actual delay to treatment among patients with localized BC.

show abstract

Increased Delay in Diagnosis, but Not Treatment, Among Patients With Oral Cancer During the COVID-19 Pandemic

Abstract: This retrospective cohort study assesses delays in diagnosis and treatment for patients with oral squamous cell carcinoma in a tertiary care University Hospital in Naples, Italy.

Cited by 8 publications

References 6 publications

The professional interactions between speech language therapist and dentist

The professional interactions between speech language therapist and dentist

Head and Neck Cancer Incidence in the United States Before and During the COVID-19 Pandemic

Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study

Contact Info

Product

Resources

About